← Leaderboards
Gregory Joseph Riggins
Johns Hopkins University
$11,126,953
Attributed
$12,853,604
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2006–24$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,400,301 · 6
CDC$3,453,303 · 2
By mechanism
U01$6,316,938 · 3
R01$5,742,256 · 2
R33$554,571 · 1
R21$239,839 · 1
P20$0 · 1
Top collaborators
- Emanuela Taioli5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Martha Allen Zeiger$2,502,243
- Stephen B Baylin$40,109,757
- Martha A Zeiger$0
- Patrizio Caturegli$4,739,009
- Bert Vogelstein$10,833,296
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaGene ExpressionMalignant NeoplasmsMutantBaseGlioblastomaFutureMutationBrain NeoplasmsApoptosisGenesTumorMolecularCharacteristicsGenomic DnaApoptoticCellsGrantEnzymesFda ApprovedAzacitidineEpigenetic ProcessCell GrowthAnimal Model
Grant awards (28)
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas$371,863
R01 · FY2024 · CA · contact PI
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas$383,606
R01 · FY2023 · CA · contact PI
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas$383,606
R01 · FY2022 · CA · contact PI
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas$391,435
R01 · FY2021 · CA · contact PI
Thyroid Cancer Aggressiveness in WTC Responders$999,987
U01 · FY2020 · OH
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas$391,435
R01 · FY2020 · CA · contact PI
Thyroid Cancer Aggressiveness in WTC Responders$999,774
U01 · FY2019 · OH
Thyroid cancer risk in WTC responders$477,269
U01 · FY2018 · OH
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas$370,575
R01 · FY2018 · CA · contact PI
Thyroid cancer risk in WTC responders$476,273
U01 · FY2017 · OH
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas$370,575
R01 · FY2017 · CA · contact PI
Thyroid cancer risk in WTC responders$500,000
U01 · FY2016 · OH
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas$370,575
R01 · FY2016 · CA · contact PI
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas$370,575
R01 · FY2015 · CA · contact PI
Preoperative and follow-up tests for thyroid tumors$277,440
R33 · FY2010 · CA · contact PI
Glioblastoma Genome Project to Locate Molecular Targets$433,974
R01 · FY2009 · NS · contact PI
Preoperative and follow-up tests for thyroid tumors$277,131
R33 · FY2009 · CA · contact PI
Glioblastoma Genome Project to Locate Molecular Targets$580,438
R01 · FY2008 · NS · contact PI
Glioblastoma Genome Project to Locate Molecular Targets$645,473
R01 · FY2007 · NS · contact PI
Glioblastoma Genome Project to Locate Molecular Targets$678,126
R01 · FY2006 · NS · contact PI
Preoperative and follow-up tests for thyroid tumors$239,839
R21 · FY2006 · CA · contact PI
A MOLECULAR CLASSIFICATION OF BRAIN TUMORS$671,885
U01 · FY2004 · CA
A MOLECULAR CLASSIFICATION OF BRAIN TUMORS$415,800
U01 · FY2003 · CA
A MOLECULAR CLASSIFICATION OF BRAIN TUMORS$200,965
U01 · FY2003 · CA
A MOLECULAR CLASSIFICATION OF BRAIN TUMORS$605,997
U01 · FY2002 · CA
LARGE SCALE GENE EXPRESSION ANALYSIS TO IDENTIFY MALIGNANT GLIOMAS$0
P20 · FY2002 · CA
A MOLECULAR CLASSIFICATION OF BRAIN TUMORS$614,714
U01 · FY2001 · CA
A MOLECULAR CLASSIFICATION OF BRAIN TUMORS$354,274
U01 · FY2000 · CA